Search Results - "Schwartz, Tyler"

Refine Results
  1. 1

    Early Audiometric Intervention in Bacterial Meningitis: Cochlear Implantation in a 10-Week-Old Child by Schwartz, Tyler R, Novak, Jessica, Scott, Alison, Patel, Sachin, Halvorson, Kyle, Jayawardena, Asitha D L

    Published in Pediatrics (Evanston) (01-08-2024)
    “…Sensorineural hearing loss is a well-known complication of Streptococcus pneumoniae meningitis. Given the propensity for fibrosis and ossification of the…”
    Get full text
    Journal Article
  2. 2

    Systemic corticosteroids for orbital complications of pediatric rhinosinusitis: A systematic review by Schwartz, Tyler R., Adams, Matthew D., Wertz, Aileen

    “…Determine if systemic corticosteroids administration is associated with reduced length of stay, surgical intervention, and abscess formation in pediatric…”
    Get full text
    Journal Article
  3. 3

    Langerhans Cell Histiocytosis of the Head and Neck: Experience at a Rural Tertiary Referral Center by Schwartz, Tyler R., Elliott, Leighton A., Fenley, Heather, Ramdas, Jagadeesh, Scott Greene, Joseph

    Published in Annals of otology, rhinology & laryngology (01-04-2023)
    “…Objectives: Retrospectively analyze head and neck Langerhans Cell Histiocytosis at a rural tertiary referral center and compare results with previously…”
    Get full text
    Journal Article
  4. 4

    Metastatic renal cell carcinoma to the thyroid with cervicothoracic venous tumor thrombosis by Hellums, Ryan N., Kovatch, Kevin J., Friscia, Michael E., Schwartz, Tyler R., Pellitteri, Phillip K.

    Published in Head & neck (01-07-2023)
    “…Introduction Metastatic renal cell carcinoma (RCC) represents 25%–42% of metastatic thyroid malignancies. Propensity for RCC to demonstrate intravascular…”
    Get full text
    Journal Article
  5. 5

    Gray-Scale Inversion on High Resolution Computed Tomography of the Temporal Bone: An Observational Study by Schwartz, Tyler R., Lindemann, Timothy Logan, Mongelluzzo, Gino, Wackym, P. Ashley, Gadre, Arun K.

    Published in Annals of otology, rhinology & laryngology (01-10-2021)
    “…Objectives: This is a qualitative study to explore the utility of gray-scale inversion or the “invert” function of high-resolution computed tomography (HRCT)…”
    Get full text
    Journal Article
  6. 6

    Transcanal incision and drainage of a parapharyngeal abscess in a pediatric patient: A novel technique by Schwartz, Tyler R., Colletta, Miranda D., McCormick, Michael E.

    “…The disease of parapharyngeal abscess is well known to the otolaryngologist and is commonly managed via transoral, transcervical, or combined incision and…”
    Get full text
    Journal Article
  7. 7

    Contralateral Gluteal Compartment Syndrome After Prolonged Use of a Fracture Table in a Scissoring Position: A Case Report by Gunn, Jenna L., Yatsonsky, David, Pasquinelly, Adam, Kosco, Ethan, Schwartz, Tyler G., Sanford, Christopher, Georgiadis, Gregory M.

    Published in JBJS case connector (01-07-2023)
    “…A 62-year-old Caucasian man presented with a comminuted subtrochanteric fracture after a low-energy fall. Physical examination postoperatively revealed a firm…”
    Get full text
    Journal Article
  8. 8

    Devoir by Schwartz, J. Tyler

    Published in Annals of emergency medicine (01-12-2018)
    Get full text
    Journal Article
  9. 9

    Green building standards and the United Nations’ Sustainable Development Goals by Goubran, Sherif, Walker, Thomas, Cucuzzella, Carmela, Schwartz, Tyler

    Published in Journal of environmental management (15-01-2023)
    “…Sustainable practices in the building industry are strongly influenced by published green and sustainable building and real-estate standards (GSBRES)…”
    Get full text
    Journal Article
  10. 10

    Monoclonal antibodies: Trends in therapeutic success and commercial focus by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-01-2023)
    “…•More than 100 new experimental antibodies now enter into development each year.•Half of experimental monoclonal antibodies and a third of approvals are…”
    Get full text
    Journal Article
  11. 11

    Antibiotic Development: Lessons from the Past and Future Opportunities by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Pharmaceutical research (01-05-2024)
    “…The challenge of antimicrobial resistance is broadly appreciated by the clinical and scientific communities. To assess progress in the development of medical…”
    Get full text
    Journal Article
  12. 12

    2023 in review: FDA approvals of new medicines by Kinch, Michael S, Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-05-2024)
    “…•2023 tied with 1996 as the year with the greatest number of new entities approved by the FDA.•Cancers have long been dominant as the target for new medicines,…”
    Get full text
    Journal Article
  13. 13

    2022 in review: FDA approvals of new medicines by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-08-2023)
    “…•The forty-four approvals by FDA in 2022 fell below recent rates but is within the long-term average.•Approvals for orphan indications captured more than half…”
    Get full text
    Journal Article
  14. 14

    2021 in review: FDA approvals of new medicines by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-08-2022)
    “…•The sixty NME approvals by FDA in 2021 was tied for the highest in post-PDUFA history.•NMEs approved for orphan indications or with an expedited or priority…”
    Get full text
    Journal Article
  15. 15

    Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-03-2023)
    “…•Immunoconjugates and bispecific antibodies are rapidly gainin in popularity.•Most immunoconjugates and bsAbs are developed for the treatment of cancer.•A…”
    Get full text
    Journal Article
  16. 16

    Sources of innovation for new medicines: questions of sustainability by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-01-2021)
    “…•Company formation peaked in the early 2000s, declining after the 2008 downturn.•Company departures (mergers, bankruptcies & quitting research) have steadily…”
    Get full text
    Journal Article
  17. 17

    2020 in review: FDA approvals of new medicines by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-12-2021)
    “…•Despite a disruptive pandemic, the FDA approved 55 NMEs in 2020, the third highest rate ever.•Orphan approvals surged to capture 60% of NMEs approved in…”
    Get full text
    Journal Article
  18. 18

    2019 in review: FDA approvals of new medicines by Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-11-2020)
    “…•The FDA approved 53 NMEs in 2019, below the prior year but higher than the five year average.•The use of the Orphan Drug Act shrank by a third, both in…”
    Get full text
    Journal Article
  19. 19

    Inter-individual variability during neurodevelopment: an investigation of linear and nonlinear resting-state EEG features in an age-homogenous group of infants by Davoudi, Saeideh, Schwartz, Tyler, Labbe, Aurélie, Trainor, Laurel, Lippé, Sarah

    Published in Cerebral cortex (New York, N.Y. 1991) (20-06-2023)
    “…Abstract Electroencephalography measures are of interest in developmental neuroscience as potentially reliable clinical markers of brain function. Features…”
    Get full text
    Journal Article
  20. 20

    Expanding roles for academic entrepreneurship in drug discovery by Kinch, Michael S., Horn, Caitlin, Kraft, Zachary, Schwartz, Tyler

    Published in Drug discovery today (01-11-2020)
    “…•Academic inventors or founders are responsible for nearly a third of NMEs approved since 2001.•The contributions of academia have progressively increased over…”
    Get full text
    Journal Article